Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin‐dependent kinases cdc2, cdk2 and cdk5 L Meijer, A Borgne, O Mulner, JPJ Chong, JJ Blow, N Inagaki, M Inagaki, ... European journal of biochemistry 243 (1‐2), 527-536, 1997 | 1616 | 1997 |
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease K Begriche, J Massart, MA Robin, F Bonnet, B Fromenty Hepatology 58 (4), 1497-1507, 2013 | 658 | 2013 |
Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver K Begriche, J Massart, MA Robin, A Borgne-Sanchez, B Fromenty Journal of hepatology 54 (4), 773-794, 2011 | 621 | 2011 |
Prediction of liver injury induced by chemicals in human with a multiparametric assay on isolated mouse liver mitochondria M Porceddu, N Buron, C Roussel, G Labbe, B Fromenty, ... Toxicological Sciences 129 (2), 332-345, 2012 | 183 | 2012 |
Sequential dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the prophase/metaphase transition A Borgne, L Meijer Journal of biological chemistry 271 (44), 27847-27854, 1996 | 182 | 1996 |
Purification of GSK-3 by affinity chromatography on immobilized axin A Primot, B Baratte, M Gompel, A Borgne, S Liabeuf, JL Romette, E Jho, ... Protein Expression and Purification 20 (3), 394-404, 2000 | 113 | 2000 |
Chemosensitization by knockdown of adenine nucleotide translocase-2 M Le Bras, A Borgne-Sanchez, Z Touat, OS El Dein, A Deniaud, E Maillier, ... Cancer Research 66 (18), 9143-9152, 2006 | 105 | 2006 |
Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition A Borgne, AC Ostvold, S Flament, L Meijer Journal of Biological Chemistry 274 (17), 11977-11986, 1999 | 77 | 1999 |
The role of cyclin-dependent kinases in apoptosis A Borgne, RM Golsteyn PROGRESS IN CELL CYCLE RESEARCH. 5, 453-460, 2003 | 68 | 2003 |
The fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells C Gallerne, Z Touat, ZX Chen, C Martel, E Mayola, N Buron, M Le Bras, ... The international journal of biochemistry & cell biology 42 (5), 623-629, 2010 | 59 | 2010 |
Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization N Buron, M Porceddu, M Brabant, D Desgué, C Racoeur, M Lassalle, ... PLoS One 5 (3), e9924, 2010 | 56 | 2010 |
Drug-induced inhibition of mitochondrial fatty acid oxidation and steatosis J Massart, K Begriche, N Buron, M Porceddu, A Borgne-Sanchez, ... Current Pathobiology Reports 1 (3), 147-157, 2013 | 48 | 2013 |
The G1/S cyclin Cig2p during meiosis in fission yeast A Borgne, H Murakami, J Ayté, P Nurse Molecular biology of the cell 13 (6), 2080-2090, 2002 | 44 | 2002 |
Therapeutic peptides: targeting the mitochondrion to modulate apoptosis E Jacotot, A Deniaud, A Borgne-Sanchez, Z Touat, JP Briand, M Le Bras, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1757 (9-10), 1312-1323, 2006 | 37 | 2006 |
Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling AE Escargueil, SY Plisov, A Skladanowski, A Borgne, L Meijer, ... The FASEB Journal 15 (12), 2288-2290, 2001 | 36 | 2001 |
Aftins Increase Amyloid-β 42, Lower Amyloid-β 38, and Do Not Alter Amyloid-β 40 Extracellular Production in vitro: Toward a Chemical Model of Alzheimer's Disease? A Hochard, N Oumata, K Bettayeb, O Gloulou, X Fant, E Durieu, N Buron, ... Journal of Alzheimer's Disease 35 (1), 107-120, 2013 | 24 | 2013 |
Pharmacological screening and enzymatic assays for apoptosis AS Belzacq-Casagrande, C Martel, C Pertuiset, A Borgne-Sanchez, ... Front Biosci 14, 3550-3562, 2009 | 24 | 2009 |
The Spd1p S phase inhibitor can activate the DNA replication checkpoint pathway in fission yeast A Borgne, P Nurse Journal of cell science 113 (23), 4341-4350, 2000 | 22 | 2000 |
A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice M Brabant, L Baux, R Casimir, JP Briand, O Chaloin, M Porceddu, ... Apoptosis 14 (10), 1190-1203, 2009 | 21 | 2009 |
Peptides Having For Example Antiangiogenic Activity and Applications Thereof In Therapeutics E Jacotot, A Borgne-Sanchez, S Dupont, D Rebouillat US Patent App. 10/573,576, 2008 | 21 | 2008 |